CIK 0001719406 · Non-accelerated filer<br>Smaller reporting company
NRX Pharmaceuticals, Inc.
Sign in to watch- Ticker
- NRXP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 822844431
- Phone
- 484-254-6134
- Business address
- 1201 ORANGE STREET, SUITE 600, WILMINGTON, DE, 19801
- Former names
- Big Rock Partners Acquisition Corp.
- 8-K Event Executive or director change · Regulation FD disclosure
- 4 Open-market buy Director bought 35,000 shares at $0.32 ($11,197)
- 4 Open-market buy Director bought 70,000 shares at $0.29 ($20,125)
- 8-K Event Material agreement · Unregistered share sale · Bylaws or fiscal year change · Regulation FD disclosure
- 8-K Event Other events
- 424B3 Offering Prospectus
- 4 Open-market buy Chief Scientist bought 100,000 shares at $0.33 ($33,000)
- 4 Open-market buy Chief Scientist bought 200,000 shares at $0.32 ($64,400)
- 8-K Event Material agreement
- 424B5 Offering Prospectus
- 10-Q Report Quarterly Report
- 8-K Event Material agreement · Delisting notice
- 424B5 Offering Prospectus
- 8-K/A Event Material agreement · Unregistered share sale · Regulation FD disclosure
- 8-K Event Material agreement · Regulation FD disclosure
- 8-K Event Material agreement · Regulation FD disclosure
- 10-K/A Report 10-K/A
- 10-Q Report Quarterly Report
- 10-K/A Report 10-K/A
- 8-K Event Delisting notice · Other events
Page 8 of 24 · 479 filings